ArticleFrontiers in pharmacology2017

P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients.

Niklas R Jørgensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.